Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the `Arbeitsgemeinschaft Internistische Onkologie'

Erstveröffentlichung

2018

Authors

Haas, Michael

Siveke, Jens T.

Schenk, Michael

Lerch, Markus M.

Caca, Karel

et al.

Beitrag zu einer Konferenz

Published in

European Journal of Cancer ; 94 (2018). - S. 95-103. - ISSN 0959-8049. - eISSN 1879-0852

Link to publication

https://dx.doi.org/10.1016/j.ejca.2018.02.008

Institutions

UKU. Klinik für Innere Medizin I

Conference

53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2017-06-02 - 2017-06-06, Chicago, IL

Subject headings

[DDC subject group]: DDC 610 / Medicine & health

---

Metadata

Show full item record